Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2014, Article ID 976364, 15 pages
http://dx.doi.org/10.1155/2014/976364
Research Article

Gene Expression Profiles Underlying Selective T-Cell-Mediated Immunity Activity of a Chinese Medicine Granule on Mice Infected with Influenza Virus H1N1

1Laboratory of Chinese Medicine on Viral Disease, Basic Medical College, Beijing University of Chinese Medicine, Beijing 100029, China
2Shanxi University of Traditional Chinese Medicine, Taiyuan, Shanxi 030024, China
3Department of Respiratory Medicine, China-Japan Friendship Hospital, Beijing 100029, China

Received 21 August 2013; Revised 25 October 2013; Accepted 18 November 2013; Published 8 January 2014

Academic Editor: V. R. Vineesh

Copyright © 2014 Na-na Lu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. E. A. Govorkova, B. M. Marathe, A. Prevost, J. E. Rehg, and R. G. Webster, “Assessment of the efficacy of the neuraminidase inhibitor oseltamivir against 2009 pandemic H1N1 influenza virus in ferrets,” Antiviral Research, vol. 91, no. 2, pp. 81–88, 2011. View at Publisher · View at Google Scholar · View at Scopus
  2. M. Barbara, V. P. Karolien, V. Veronique, E. Vermeire, and S. Coenen, “The value of neuraminidase inhibitors for the prevention and treatment of seasonal influenza: a systematic review of systematic reviews,” PLoS ONE, vol. 8, no. 4, Article ID e60348, 2013. View at Publisher · View at Google Scholar
  3. C. Wang, B. Cao, Q. Q. Liu et al., “Oseltamivir compared with the Chinese traditional therapy maxingshigan-yinqiaosan in the treatment of H1N1 influenza: a randomized trial,” Annals of Internal Medicine, vol. 155, no. 4, pp. 217–225, 2011. View at Google Scholar · View at Scopus
  4. Y. F. Luo, “Clinical research of professor CHAO En-xiang's experience in treating flu with Chinese herbs,” Beijing Journal of Traditional Chinese Medicine, vol. 31, no. 11, pp. 836–839, 2012. View at Google Scholar
  5. L. J. Reed and H. J. Muench, “A simple method of estimating fifty per cent endpoints,” The American Journal of Epidemiology, vol. 27, no. 3, pp. 493–497, 1938. View at Google Scholar · View at Scopus
  6. T. D. Schmittgen and K. J. Livak, “Analyzing real-time PCR data by the comparative C(T) method,” Nature Protocols, vol. 3, no. 6, pp. 1101–1108, 2008. View at Publisher · View at Google Scholar · View at Scopus
  7. M. Michaelis, J. Geiler, P. Naczk et al., “Glycyrrhizin exerts antioxidative effects in H5N1 influenza A virus-infected cells and inhibits virus replication and pro-inflammatory gene expression,” PLoS ONE, vol. 6, no. 5, Article ID e19705, 2011. View at Publisher · View at Google Scholar · View at Scopus
  8. S. Maschalidi, S. Hässler, F. Blanc et al., “Asparagine endopeptidase controls anti-influenza virus immune responses through TLR7 activation,” PLoS Pathogens, vol. 8, no. 8, Article ID e1002841, 2012. View at Publisher · View at Google Scholar
  9. S. U. Seo, H. J. Kwon, J. H. Song et al., “MyD88 signaling is indispensable for primary influenza A virus infection but dispensable for secondary infection,” Journal of Virology, vol. 84, no. 24, pp. 12713–12722, 2010. View at Publisher · View at Google Scholar · View at Scopus
  10. L. Jirmanova, M. L. G. Torchia, N. D. Sarma, P. R. Mittelstadt, and J. D. Ashwell, “Lack of the T cell-specific alternative p38 activation pathway reduces autoimmunity and inflammation,” Blood, vol. 118, no. 12, pp. 3280–3289, 2011. View at Publisher · View at Google Scholar · View at Scopus
  11. T. Yamano, S. Murata, N. Shimbara et al., “Two distinct pathways mediated by PA28 and hsp90 in major histocompatibility complex class I antigen processing,” Journal of Experimental Medicine, vol. 196, no. 2, pp. 185–196, 2002. View at Publisher · View at Google Scholar · View at Scopus
  12. G. Li, J. Zhang, X. Tong, W. Liu, and X. Ye, “Heat shock protein 70 inhibits the activity of influenza a virus ribonucleoprotein and blocks the replication of virus in vitro and in vivo,” PLoS ONE, vol. 6, no. 2, Article ID e16546, 2011. View at Publisher · View at Google Scholar · View at Scopus
  13. J. L. Nayak, K. A. Richards, F. A. Chaves, and A. J. Sant, “Analyses of the specificity of CD4 T cells during the primary immune response to influenza virus reveals dramatic MHC-linked asymmetries in reactivity to individual viral proteins,” Viral Immunology, vol. 23, no. 2, pp. 169–180, 2010. View at Publisher · View at Google Scholar · View at Scopus
  14. H. Ayukawa, T. Matsubara, M. Kaneko, M. Hasegawa, T. Ichiyama, and S. Furukawa, “Expression of CTLA-4 (CD152) in peripheral blood T cells of children with influenza virus infection including encephalopathy in comparison with respiratory syncytial virus infection,” Clinical and Experimental Immunology, vol. 137, no. 1, pp. 151–155, 2004. View at Publisher · View at Google Scholar · View at Scopus
  15. H. Bour-Jordan, J. L. Grogan, Q. Tang, J. A. Auger, R. M. Locksley, and J. A. Bluestone, “CTLA-4 regulates the requirement for cytokine-induced signals in T(H)2 lineage commitment,” Nature Immunology, vol. 4, no. 2, pp. 182–188, 2003. View at Publisher · View at Google Scholar · View at Scopus
  16. H. Schneider, J. Downey, A. Smith et al., “Reversal of the TCR stop signal by CTLA-4,” Science, vol. 313, no. 5795, pp. 1972–1975, 2006. View at Publisher · View at Google Scholar · View at Scopus
  17. S. Gao, L. Song, J. Li et al., “Influenza A virus-encoded NS1 virulence factor protein inhibits innate immune response by targeting IKK,” Cellular Microbiology, vol. 14, no. 12, pp. 1849–1866, 2012. View at Publisher · View at Google Scholar
  18. K. Gotoh, Y. Tanaka, A. Nishikimi et al., “Selective control of type I IFN induction by the Rac activator DOCK2 during TLR-mediated plasmacytoid dendritic cell activation,” Journal of Experimental Medicine, vol. 207, no. 4, pp. 721–730, 2010. View at Publisher · View at Google Scholar · View at Scopus
  19. P. Rao, M. S. Hayden, M. Long et al., “IκBβ acts to inhibit and activate gene expression during the inflammatory response,” Nature, vol. 466, no. 7310, pp. 1115–1119, 2010. View at Publisher · View at Google Scholar
  20. J. M. Clark, K. Aleksiyadis, A. Martin et al., “Inhibitor of κ B epsilon (IκBε) is a non-redundant regulator of c-Rel-dependent gene expression in murine T and B cells,” PLoS ONE, vol. 6, no. 9, Article ID e24504, 2011. View at Publisher · View at Google Scholar
  21. D. Mucida, M. M. Husain, S. Muroi et al., “Transcriptional reprogramming of mature CD4+ helper T cells generates distinct MHC class II-restricted cytotoxic T lymphocytes,” Nature Immunology, vol. 14, no. 3, pp. 281–289, 2013. View at Publisher · View at Google Scholar
  22. A. Sundararajan, L. Huan, K. A. Richards et al., “Host differences in influenza-specific CD4 T cell and B cell responses are modulated by viral strain and route of immunization,” PLoS ONE, vol. 7, no. 3, Article ID e34377, 2012. View at Publisher · View at Google Scholar
  23. S. R. Kumar, S. M. S. Khader, T. K. Kiener, M. Szyporta, and J. Kwang, “Intranasal immunization of baculovirus displayed hemagglutinin confers complete protection against mouse adapted highly pathogenic H7N7 reassortant influenza virus,” PLoS ONE, vol. 8, no. 6, Article ID e63856, 2013. View at Publisher · View at Google Scholar
  24. X. Gu, P. Li, H. Liu, N. Li, S. Li, and T. Sakuma, “The effect of influenza virus A on th1/th2 balance and alveolar fluid clearance in pregnant rats,” Experimental Lung Research, vol. 37, no. 7, pp. 445–451, 2011. View at Publisher · View at Google Scholar · View at Scopus
  25. Q. Liu, L. G. Gu, N. N. Lu et al., “Protection effect of Shu Feng Xuan Fei Formula and Jie Biao Qing Li Formula on lung injury of mice infected with influenza virus,” China Journal of TCM and Pharmacy, vol. 27, no. 7, pp. 2132–2134, 2013. View at Google Scholar
  26. N. N. Lu, L. G. Gu, Q. Liu et al., “Screening for genes associated with natural killer cell-mediated cytotoxicity in pneumonia mice infected with influenza virus and regulation of two herbal anti-virus formulas,” Chinese Critical Care Medicine, vol. 25, no. 6, pp. 322–326, 2013. View at Google Scholar
  27. P. Sithisarn, M. Michaelis, M. Schubert-Zsilavecz, and J. Cinatl Jr., “Differential antiviral and anti-inflammatory mechanisms of the flavonoids biochanin A and baicalein in H5N1 influenza A virus-infected cells,” Antiviral Research, vol. 97, no. 1, pp. 41–48, 2013. View at Publisher · View at Google Scholar
  28. S. Liu, J. Yan, J. Xing, F. Song, Z. Liu, and S. Liu, “Characterization of compounds and potential neuraminidase inhibitors from the n-butanol extract of compound indigowoad root granule using ultrafiltration and liquid chromatography-tandem mass spectrometry,” Journal of Pharmaceutical and Biomedical Analysis, vol. 59, no. 1, pp. 96–101, 2012. View at Publisher · View at Google Scholar · View at Scopus
  29. Z. Liu, Z. Q. Yang, and H. Xiao, “Antiviral activity of the effective monomers from folium isatidis against influenza virus in vivo,” Virologica Sinica, vol. 25, no. 6, pp. 445–451, 2010. View at Publisher · View at Google Scholar · View at Scopus
  30. W. Zhou, H. D. Wang, X. X. Zhu et al., “Improvement of intestinal absorption of forsythoside A and chlorogenic acid by different carboxymethyl chitosan and chito-oligosaccharide, application to Flos Lonicerae-Fructus Forsythiae herb couple preparations,” PLoS ONE, vol. 8, no. 5, Article ID e63348, 2013. View at Publisher · View at Google Scholar
  31. T. Nagai, Y. Suzuki, T. Tomimori, and H. Yamada, “Antiviral activity of plant flavonoid 5,7,4′-trihydroxy-8-methoxyflavone, from the roots of Scutellaria baicalensis against influenza A (H3N2) and B virus,” Biological and Pharmaceutical Bulletin, vol. 18, no. 2, pp. 295–299, 1995. View at Google Scholar · View at Scopus
  32. E. K. Shin, D. H. Kim, H. Lim, H. K. Shin, and J. K. Kim, “The anti-inflammatory effects of a methanolic extract from radix isatidis in murine macrophages and mice,” Inflammation, vol. 33, no. 2, pp. 110–118, 2010. View at Publisher · View at Google Scholar · View at Scopus